REPORT ID 14018

Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Survey Report 2017

Publish Date
22-Nov-17
Pages
106
Format
Electronic (PDF)

This report studies Nuclear Medicine & Radio Pharmaceuticals in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    GE Healthcare
    Philips Healthcare
    Siemens Healthcare
    Toshiba
    Hitachi
    Carestream
    Esaote
    Shimadzu
    TriFoil Imaging
    Biosensors International Group, Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

By Application, the market can be split into
    Diagnostic Applications: SPECT, PET.
    Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Survey Report 2017
1 Industry Overview of Nuclear Medicine & Radio Pharmaceuticals
    1.1 Definition and Specifications of Nuclear Medicine & Radio Pharmaceuticals
        1.1.1 Definition of Nuclear Medicine & Radio Pharmaceuticals
        1.1.2 Specifications of Nuclear Medicine & Radio Pharmaceuticals
    1.2 Classification of Nuclear Medicine & Radio Pharmaceuticals
        1.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
        1.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    1.3 Applications of Nuclear Medicine & Radio Pharmaceuticals
        1.3.1 Diagnostic Applications: SPECT, PET.
        1.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
        1.3.3 Application 3
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radio Pharmaceuticals
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radio Pharmaceuticals
    2.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
    2.4 Industry Chain Structure of Nuclear Medicine & Radio Pharmaceuticals

3 Technical Data and Manufacturing Plants Analysis of Nuclear Medicine & Radio Pharmaceuticals
    3.1 Capacity and Commercial Production Date of Global Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2016

4 Global Nuclear Medicine & Radio Pharmaceuticals Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Nuclear Medicine & Radio Pharmaceuticals Capacity and Growth Rate Analysis
        4.2.2 2016 Nuclear Medicine & Radio Pharmaceuticals Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Analysis
        4.3.2 2016 Nuclear Medicine & Radio Pharmaceuticals Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Nuclear Medicine & Radio Pharmaceuticals Sales Price
        4.4.2 2016 Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis (Company Segment)

5 Nuclear Medicine & Radio Pharmaceuticals Regional Market Analysis
    5.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Analysis
        5.1.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Overview
        5.1.2 North America 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
        5.1.4 North America 2016 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    5.2 China Nuclear Medicine & Radio Pharmaceuticals Market Analysis
        5.2.1 China Nuclear Medicine & Radio Pharmaceuticals Market Overview
        5.2.2 China 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
        5.2.4 China 2016 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    5.3 Europe Nuclear Medicine & Radio Pharmaceuticals Market Analysis
        5.3.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Overview
        5.3.2 Europe 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
        5.3.4 Europe 2016 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    5.4 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Analysis
        5.4.1 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Overview
        5.4.2 Southeast Asia 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
        5.4.4 Southeast Asia 2016 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    5.5 Japan Nuclear Medicine & Radio Pharmaceuticals Market Analysis
        5.5.1 Japan Nuclear Medicine & Radio Pharmaceuticals Market Overview
        5.5.2 Japan 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
        5.5.4 Japan 2016 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    5.6 India Nuclear Medicine & Radio Pharmaceuticals Market Analysis
        5.6.1 India Nuclear Medicine & Radio Pharmaceuticals Market Overview
        5.6.2 India 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
        5.6.4 India 2016 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis

6 Global 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Sales by Type
    6.2 Different Types of Nuclear Medicine & Radio Pharmaceuticals Product Interview Price Analysis
    6.3 Different Types of Nuclear Medicine & Radio Pharmaceuticals Product Driving Factors Analysis
        6.3.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals of Nuclear Medicine & Radio Pharmaceuticals Growth Driving Factor Analysis
        6.3.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes of Nuclear Medicine & Radio Pharmaceuticals Growth Driving Factor Analysis

7 Global 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Nuclear Medicine & Radio Pharmaceuticals Consumption by Application
    7.2 Different Application of Nuclear Medicine & Radio Pharmaceuticals Product Interview Price Analysis
    7.3 Different Application of Nuclear Medicine & Radio Pharmaceuticals Product Driving Factors Analysis
        7.3.1 Diagnostic Applications: SPECT, PET. of Nuclear Medicine & Radio Pharmaceuticals Growth Driving Factor Analysis
        7.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. of Nuclear Medicine & Radio Pharmaceuticals Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Nuclear Medicine & Radio Pharmaceuticals
    8.1 GE Healthcare
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 GE Healthcare 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 GE Healthcare 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis
    8.2 Philips Healthcare
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Philips Healthcare 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Philips Healthcare 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis
    8.3 Siemens Healthcare
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Siemens Healthcare 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Siemens Healthcare 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis
    8.4 Toshiba
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Toshiba 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Toshiba 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis
    8.5 Hitachi
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Hitachi 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Hitachi 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis
    8.6 Carestream
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Carestream 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Carestream 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis
    8.7 Esaote
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Esaote 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Esaote 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis
    8.8 Shimadzu
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Shimadzu 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Shimadzu 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis
    8.9 TriFoil Imaging
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 TriFoil Imaging 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 TriFoil Imaging 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis
    8.10 Biosensors International Group, Ltd
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Biosensors International Group, Ltd 2016 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Biosensors International Group, Ltd 2016 Nuclear Medicine & Radio Pharmaceuticals Business Region Distribution Analysis

9 Development Trend of Analysis of Nuclear Medicine & Radio Pharmaceuticals Market
    9.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Trend Analysis
        9.1.1 Global 2017-2022 Nuclear Medicine & Radio Pharmaceuticals Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Nuclear Medicine & Radio Pharmaceuticals Sales Price Forecast
    9.2 Nuclear Medicine & Radio Pharmaceuticals Regional Market Trend
        9.2.1 North America 2017-2022 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
        9.2.2 China 2017-2022 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
        9.2.3 Europe 2017-2022 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
        9.2.5 Japan 2017-2022 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
        9.2.6 India 2017-2022 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
    9.3 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Product Type)
    9.4 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Application)

10 Nuclear Medicine & Radio Pharmaceuticals Marketing Type Analysis
    10.1 Nuclear Medicine & Radio Pharmaceuticals Regional Marketing Type Analysis
    10.2 Nuclear Medicine & Radio Pharmaceuticals International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Nuclear Medicine & Radio Pharmaceuticals by Region
    10.4 Nuclear Medicine & Radio Pharmaceuticals Supply Chain Analysis

11 Consumers Analysis of Nuclear Medicine & Radio Pharmaceuticals
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source